Professional Documents
Culture Documents
Bioethics J Artificial Organs J Stem Cells
Bioethics J Artificial Organs J Stem Cells
In Vitro Fertilization
Induce(pinilit) Pluripotent Stem Cells
• Assisted reproductive technology (ART)
that involves fertilizing egg with sperm • These stem cells are created or induce
outside the body, in vitro, and then in the laboratory
implanting the fertilized embryo into the • Unlike embryonic stem cells, which are
uterus. naturally found in embryos, IPCs are
• Process Overview generated by reprogramming adult cells
o Stimulation of ovaries • Induces the adult cells to regain
o Egg retrieval pluripotency, meaning they regain the
o Fertilization
ability to differentiate into various cell • Fundamental disagreements about
types, similar to embryonic stem cells when life begins contribute to ethical
dilemmas
• Balancing scientific progress with the
moral responsibility to respect and
protect human life.
Pros iPS cell technology
• Eliminates the need for embryos in the
generation of pluripotent stem cells
• Can be created from a patient’s own
cells, reducing the risk of rejection in
therapeutic applications
• Valuable tool for studying diseases in a
controlled environment
• Can be directed to become specific cell
types needed for specific therapies
Cons iPS cell technology
• iPSCs derived from a patient with a
genetic defect will retain the same
genetic defect abnormalities
• Potential for genetic mutations or
abnormal cell behavior
• Have the potential to form tumors,
raising concerns about their safety for
clinical applications
• Can be complex and costly
Bone Marrow
• Soft and spongy tissue inside bones that
plays a crucial role in the body’s blood
and immune system
• Houses hematopoietic stem cells
(HSCs) a type of multipotent stem cell
• HSC’s give rise to various blood cells,
including red blood cells, white blood
cells, and platelets
• Treat patients diagnosed with leukemia,
aplastic anemia, and lymphomas
• Need for greater histocompatibility
Technical Challenges
• Cell differentiation control
• Genetic stability
• Immunocompatibility issues
• Tissue integration
• Ethical considerations
• Scalability and production efficiency
• Long- term safety and efficacy
• Transitioning from preclinical success
to successful clinical applications